Andere Sprachen Mydecine Innovations Group Inc. NEO Exchange

Aktien

A2P6ED

CA62849F2008

MYCO

Schlusskurs NEO Exchange Andere Börsenplätze 00:00:00 06.10.2023			% 5 Tage	% 1. Jan.
0,175 ^CAD	+45,83 %		+29,63 %	-61,11 %

23.02.	Mydecine Innovations schließt teilweisen Schuldenvergleich ab	MT
02.02.	Mydecine Innovations Group Inc. gibt den Rücktritt von Neil Stevenson-Moore als Direktor bekannt	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Mydecine Applies for Management Cease Trade Order	03.05.
Mydecine Receives Management Cease Trade Order	03.05.
Mydecine Innovations Group Inc. Announces Restructuring Transactions and Annual General and Special Meeting	02.05.
Mydecine Innovations Group Inc. announced that it expects to receive CAD 1 million in funding	01.05.
Mydecine Announces Intention to Refile Certain Financial Statements and Applies for Management Cease Trade Order	26.04.
Mydecine Innovations Group Inc. Announces Share for Debt Settlement	20.03.
Mydecine Innovations Closes Partial Debt Settlement	23.02.
Mydecine Innovations Group Receives Two Notice of Allowances from USPTO for its MYCO-005 and MYCO-006 Family of Compounds	07.02.
Mydecine Innovations Group Receives Two Notice of Allowances from USPTO for its MYCO-005 and MYCO-006 Family of Compounds	07.02.
Mydecine Innovations Group Announces Director Resignation	02.02.
Mydecine Innovations Group Inc Announces Resignation of Neil Stevenson-Moore as Director	02.02.
Mydecine Innovations Group Receives Notice of Allowance from USPTO For MYCO-005 Compound	18.12.
Mydecine Innovations Group Receives Notice of Allowance from USPTO for its MYCO-005 Compound	18.12.
Mydecine Announces Update Regarding the Special Access Program	28.11.
Mydecine Innovations Group Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	18.11.
Mydecine Innovations Group Files Prospectus Supplement, Announces Closing Under Share Subscription Agreements	31.10.23
Mydecine Innovations Group Files Prospectus Supplement, Announces Closing Under Share Subscription Agreements	31.10.23
Mydecine Innovations Group Provided Q4 2023 Business Update	26.10.23
Mydecine Provides Q4 2023 Business Update	26.10.23
Mydecine Provides Q4 2023 Business Update	26.10.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Mydecine Innovations Group Inc. NEO Exchange

Aktien

A2P6ED

CA62849F2008

MYCO

Andere Sprachen

Filter